Literature DB >> 23800105

Pharmacologic management of diabetic peripheral neuropathic pain.

Shridhar Iyer1, Robert J Tanenberg.   

Abstract

INTRODUCTION: Diabetic peripheral neuropathic pain (DPNP) is a debilitating and distressing complication that occurs in patients with diabetes mellitus. This article provides an overview of diabetic peripheral neuropathy focusing on DPNP. AREAS COVERED: This article reviews the diagnosis, pathogenesis, prevention and treatment of diabetic neuropathy and neuropathic pain. A comprehensive and systematic Medline search of the published literature for treatment of diabetic peripheral neuropathy was done from 1965 to December 2012. Studies not in English language were excluded. EXPERT OPINION: Neuropathic pain is difficult to treat, and patients rarely experience complete pain relief. Despite several pharmacological agents being used in the treatment of DPNP, only duloxetine and pregabalin have evidence-based support for controlling DPNP.

Entities:  

Mesh:

Year:  2013        PMID: 23800105     DOI: 10.1517/14656566.2013.811490

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  10 in total

1.  Burden of Illness of Diabetic Peripheral Neuropathic Pain: A Qualitative Study.

Authors:  Meryl Brod; Betsy Pohlman; Steven I Blum; Abhilasha Ramasamy; Robyn Carson
Journal:  Patient       Date:  2015-08       Impact factor: 3.883

2.  Alleviative effect of microRNA-497 on diabetic neuropathic pain in rats in relation to decreased USP15.

Authors:  Tonghui Zhang; Ling Wang; Ling Chen
Journal:  Cell Biol Toxicol       Date:  2022-04-27       Impact factor: 6.691

3.  Luteolin improves the impaired nerve functions in diabetic neuropathy: behavioral and biochemical evidences.

Authors:  Ming Li; Qiang Li; Qingsong Zhao; Jinchao Zhang; Jiang Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 4.  Pathways in the diagnosis and management of diabetic polyneuropathy.

Authors:  Michelle Kaku; Aaron Vinik; David M Simpson
Journal:  Curr Diab Rep       Date:  2015-06       Impact factor: 4.810

Review 5.  Tapentadol extended release in the management of peripheral diabetic neuropathic pain.

Authors:  Nalini Vadivelu; Alice Kai; Benjamin Maslin; Gopal Kodumudi; Aron Legler; Jack M Berger
Journal:  Ther Clin Risk Manag       Date:  2015-01-14       Impact factor: 2.423

Review 6.  Updates in diabetic peripheral neuropathy.

Authors:  Kelsey Juster-Switlyk; A Gordon Smith
Journal:  F1000Res       Date:  2016-04-25

7.  Knowledge, Perceptions and Attitudes toward Chronic Pain and Its Management: A Cross-Sectional Survey of Frontline Pharmacists in Ontario, Canada.

Authors:  Tejal Patel; Feng Chang; Heba Tallah Mohammed; Lalitha Raman-Wilms; Jane Jurcic; Ayesha Khan; Beth Sproule
Journal:  PLoS One       Date:  2016-06-07       Impact factor: 3.240

8.  Ammoxetine attenuates diabetic neuropathic pain through inhibiting microglial activation and neuroinflammation in the spinal cord.

Authors:  Ting-Ting Zhang; Rui Xue; Shi-Yong Fan; Qiong-Yin Fan; Lei An; Juan Li; Lei Zhu; Yu-Hua Ran; Li-Ming Zhang; Bo-Hua Zhong; Yun-Feng Li; Cai-Ying Ye; You-Zhi Zhang
Journal:  J Neuroinflammation       Date:  2018-06-07       Impact factor: 8.322

9.  Painful Diabetic Peripheral Neuropathy Study of Chinese OutPatiEnts (PDN-SCOPE): protocol for a multicentre cross-sectional registry study of clinical characteristics and treatment in China.

Authors:  Yuanjin Zhang; Nan Li; Yiming Zhao; Dongsheng Fan
Journal:  BMJ Open       Date:  2019-04-08       Impact factor: 2.692

Review 10.  New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors.

Authors:  Prabhakar Busa; Yaswanth Kuthati; Niancih Huang; Chih-Shung Wong
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.